Treace Medical Concepts (TMCI) Gross Margin (2020 - 2026)
Treace Medical Concepts (TMCI) posted Gross Margin of 79.26% for Q1 2026, down 1.69% on a QoQ basis from 80.62% in Q4 2025, and down 43.0% year-over-year from 139.04% in Q1 2025.
Treace Medical Concepts (TMCI) Gross Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Gross Margin history runs 7 years deep, the most recent figure standing at 79.26% for Q1 2026.
- Quarterly Gross Margin fell 43.0% year-over-year to 79.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79.72% (down 53.0% YoY) and the FY2025 annual result came in at 79.81%, down 56.0% from the prior year.
- Gross Margin was 79.26% for Q1 2026 at Treace Medical Concepts, down from 80.62% in the prior quarter.
- Across five years, Gross Margin topped out at 82.34% in Q2 2022 and bottomed at 79.07% in Q3 2025.
- A 5-year average of 80.73% and a median of 80.62% in 2025 frame the typical range for Gross Margin.
- Peak annual rise in Gross Margin reached 144 bps in 2022, while the deepest fall reached 207 bps in 2022.
- Treace Medical Concepts' Gross Margin stood at 81.87% in 2022, then decreased by 0 bps to 81.56% in 2023, then dropped by 1 bps to 80.74% in 2024, then retreated by 0 bps to 80.62% in 2025, then declined by 2 bps to 79.26% in 2026.
- Business Quant data shows TMCI's Gross Margin at 79.26% in Q1 2026, 80.62% in Q4 2025, and 79.07% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 79.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.26% |
| Dec 31, 2025 | 80.62% |
| Sep 30, 2025 | 79.07% |
| Jun 30, 2025 | 79.67% |
| Mar 31, 2025 | 79.69% |
| Dec 31, 2024 | 80.74% |
| Sep 30, 2024 | 80.14% |
| Jun 30, 2024 | 80.25% |
| Mar 31, 2024 | 80.19% |
| Dec 31, 2023 | 81.56% |
| Sep 30, 2023 | 80.38% |
| Jun 30, 2023 | 81.71% |
| Mar 31, 2023 | 80.95% |
| Dec 31, 2022 | 81.87% |
| Sep 30, 2022 | 81.58% |
| Jun 30, 2022 | 82.34% |
| Mar 31, 2022 | 82.34% |
| Dec 31, 2021 | 83.94% |
| Sep 30, 2021 | 80.35% |
| Jun 30, 2021 | 80.90% |